PharmacyCodes



Isosorbidi Mononitras [Latin] en es it fr

Isosorbidi Mononitras [Latin] Brand names, Isosorbidi Mononitras [Latin] Analogs

Isosorbidi Mononitras [Latin] Brand Names Mixture

  • No information avaliable

Isosorbidi Mononitras [Latin] Chemical_Formula

C6H9NO6

Isosorbidi Mononitras [Latin] RX_link

http://www.rxlist.com/cgi/generic/isomono2.htm

Isosorbidi Mononitras [Latin] fda sheet

http://www.fda.gov/cder/foi/anda/98/75-147_Isosorbide.htm

Isosorbidi Mononitras [Latin] msds (material safety sheet)

Isosorbidi_Mononitras_[Latin] MSDS

Isosorbidi Mononitras [Latin] Synthesis Reference

Hayward et al., Can.J.Chem., 45; 2191-2192 (1967)

Isosorbidi Mononitras [Latin] Molecular Weight

191.139 g/mol

Isosorbidi Mononitras [Latin] Melting Point

88-91oC

Isosorbidi Mononitras [Latin] H2O Solubility

1.07E+005 mg/L

Isosorbidi Mononitras [Latin] State

Solid

Isosorbidi Mononitras [Latin] LogP

-0.15

Isosorbidi Mononitras [Latin] Dosage Forms

Tablet (immediate release); Tablet (extended release)

Isosorbidi Mononitras [Latin] Indication

For the prevention of angina pectoris due to coronary artery disease and the treatment of acute and chronic angina pectoris, hypertension, and myocardial infarction.

Isosorbidi Mononitras [Latin] Pharmacology

Isosorbide-5-mononitrate, the long-acting metabolite of isosorbide dinitrate, is used as a vasodilatory agent in the management of angina pectoris. By dilating the vessels, it lowers the blood pressure and reduces the left ventricular preload and afterload, therefore, leads to a reduction of myocardial oxygen requirement.

Isosorbidi Mononitras [Latin] Absorption

100%

Isosorbidi Mononitras [Latin] side effects and Toxicity

Symptoms of overdose include vasodilatation, venous pooling, reduced cardiac output, and hypotension. LD50=mg/kg(orally in rat)

Isosorbidi Mononitras [Latin] Patient Information

Isosorbidi Mononitras [Latin] Organisms Affected

Humans and other mammals